Refreshing results…
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial
Download from doi.orgEvolving therapeutic landscape of advanced hepatocellular carcinoma
UploadNOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
Download from aacrjournals.orgEGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma
Download from www.nature.comEGFR activation limits the response of liver cancer to lenvatinib
Download from www.nature.comExploring liver cancer biology through functional genetic screens
Download from www.nature.comElongation factor ELOF1 drives transcription-coupled repair and prevents genome instability
UploadMultiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Download from www.nature.comMissing publications? Search for publications with a matching author name.